| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Farrow Jeffrey S is a See Remarks at Tarsus Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | TARS Tarsus Pharmaceuticals, Inc. | See Remarks | Sale+OE | 13,608 | $40.42 | $550,035.36 | -27.0% | +25.8% | - | |
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | See Remarks | Sell | 3,724 | $47.88 | $178,306.42 | -5.0% | -17.7% | +29.3% | |
| Jun 18, 2024 | TARS Tarsus Pharmaceuticals, Inc. | See Remarks | Sale+OE | 10,445 | $27.47 | $286,924.15 | -36.5% | +16.9% | +50.5% |